Morgan Stanley
STTK icon

Morgan Stanley’s Shattuck Labs STTK Stock Holding History

Morgan Stanley’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Sell
181,712
-18,424
-9% -$115K ﹤0.01% 5102
2026
Q1 		$1.29M Buy
200,136
+182,028
+1,005% +$863K ﹤0.01% 5019
2025
Q4 		$66.1K Buy
18,108
+1,457
+9% +$3.48K ﹤0.01% 6349
2025
Q3 		$39.8K Sell
16,651
-7,437
-31% -$9.1K ﹤0.01% 6478
2025
Q2 		$19.1K Sell
24,088
-56,291
-70% -$54.6K ﹤0.01% 6662
2025
Q1 		$76.4K Sell
80,379
-197,551
-71% -$243K ﹤0.01% 6130
2024
Q4 		$336K Buy
277,930
+321
+0.1% +$398 ﹤0.01% 5580
2024
Q3 		$969K Buy
277,609
+57,816
+26% +$216K ﹤0.01% 5061
2024
Q2 		$848K Buy
219,793
+117,799
+115% +$958K ﹤0.01% 5058
2024
Q1 		$912K Buy
101,994
+91,109
+837% +$834K ﹤0.01% 5004
2023
Q4 		$77.6K Buy
10,885
+7,809
+254% +$21.3K ﹤0.01% 6038
2023
Q3 		$4.68K Hold
3,076
– – ﹤0.01% 6929
2023
Q2 		$9.6K Sell
3,076
-21,839
-88% -$63.4K ﹤0.01% 6827
2023
Q1 		$73.3K Buy
24,915
+21,412
+611% +$75.7K ﹤0.01% 6130
2022
Q4 		$8.06K Sell
3,503
-512,467
-99% -$1.28M ﹤0.01% 7010
2022
Q3 		$1.39M Sell
515,970
-264,792
-34% -$994K ﹤0.01% 4667
2022
Q2 		$3.17M Sell
780,762
-67,675
-8% -$245K ﹤0.01% 4149
2022
Q1 		$3.61M Sell
848,437
-454,345
-35% -$2.58M ﹤0.01% 4029
2021
Q4 		$11.1M Buy
1,302,782
+1,043,410
+402% +$14.4M ﹤0.01% 2842
2021
Q3 		$5.29M Buy
259,372
+204,620
+374% +$4.38M ﹤0.01% 3625
2021
Q2 		$1.59M Buy
54,752
+52,647
+2,501% +$1.54M ﹤0.01% 4804
2021
Q1 		$62K Sell
2,105
-9,850
-82% -$414K ﹤0.01% 6256
2020
Q4 		$626K Buy
+11,955
New +$384K ﹤0.01% 4937

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley's STTK Position: Q2 2026 in Review

Morgan Stanley reduced its Shattuck Labs (STTK) stake by 9.2% in Q2 2026, selling an estimated $115K and leaving 181,712 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #5102.

Morgan Stanley first reported a position in STTK in Q4 2020 and has held it in 23 quarters since. The position peaked at $11.1M in Q4 2021. 100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • Morgan Stanley held 181,712 shares of Shattuck Labs worth $1.26M as of Q2 2026.
  • Morgan Stanley sold 18,424 Shattuck Labs shares in Q2 2026, an estimated $115K.
  • Shattuck Labs made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5102 holding.
  • Morgan Stanley first reported a position in Shattuck Labs in Q4 2020 and has held it in 23 quarters since.
  • Morgan Stanley's Shattuck Labs position peaked at $11.1M in Q4 2021.
  • 100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.